Related references
Note: Only part of the references are listed.Tumor-derived exosomes: Key players in non-small cell lung cancer metastasis and their implication for targeted therapy
Maryam Noor Rizwan et al.
MOLECULAR CARCINOGENESIS (2022)
PD-L1 interacts with Frizzled 6 to activate β-catenin and form a positive feedback loop to promote cancer stem cell expansion
Lingchen Fu et al.
ONCOGENE (2022)
miR-199a-3p/5p regulate tumorgenesis via targeting Rheb in non-small cell lung cancer
Xiaomin Liu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2022)
Clinicopathological and molecular characteristics associated with PD-L1 expression in non-small cell lung cancer: a large-scale, multi-center, real-world study in China
Qiang Zheng et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2021)
The DNA methylation landscape of PD-1 (PDCD1) and adjacent lncRNA AC131097.3 in head & neck squamous cell carcinoma
Christopher Bockhorst et al.
EPIGENOMICS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Predictive biomarkers of anti-PD-1/PD-L1 therapy in NSCLC
Mengke Niu et al.
EXPERIMENTAL HEMATOLOGY & ONCOLOGY (2021)
Epithelial Membrane Protein 2 Suppresses Non-Small Cell Lung Cancer Cell Growth by Inhibition of MAPK Pathway
Yunxia Ma et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Blocking Wnt/β-catenin Signal Amplifies Anti-PD-1 Therapeutic Efficacy by Inhibiting Tumor Growth, Migration, and Promoting Immune Infiltration in Glioblastomas
Hui Zhang et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Current understanding of cancer-intrinsic PD-L1: regulation of expression and its protumoral activity
Pedram Yadollahi et al.
BMB REPORTS (2021)
PD-L1 gene promoter methylation represents a potential diagnostic marker in advanced gastric cancer
Dan Lv et al.
ONCOLOGY LETTERS (2020)
Non-Exosomal and Exosomal Circulatory MicroRNAs: Which Are More Valid as Biomarkers?
Nik Nur Syazana Binti Nik Mohamed Kamal et al.
FRONTIERS IN PHARMACOLOGY (2020)
PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer
Wendan Yu et al.
CELL DEATH & DISEASE (2020)
β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion
Linyong Du et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
The Extrinsic and Intrinsic Roles of PD-L1 and Its Receptor PD-1: Implications for Immunotherapy Treatment
Katie Hudson et al.
FRONTIERS IN IMMUNOLOGY (2020)
MiR-873/PD-L1 axis regulates the stemness of breast cancer cells
Lanlan Gao et al.
EBIOMEDICINE (2019)
Mismatch repair deficiency/microsatellite instability-high as a predictor for anti-PD-1/PD-L1 immunotherapy efficacy
Pengfei Zhao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Association Between Tumor Mutation Burden (TMB) and Outcomes of Cancer Patients Treated With PD-1/PD-L1 Inhibitions: A Meta-Analysis
Jiaxin Zhu et al.
FRONTIERS IN PHARMACOLOGY (2019)
The role of PD-L1 expression as a predictive biomarker: an analysis of all US Food and Drug Administration (FDA) approvals of immune checkpoint inhibitors
Andrew A. Davis et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
MiR-200b-3p Functions as an Oncogene by Targeting ABCA1 in Lung Adenocarcinoma
Keqiang Liu et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2019)
MicroRNA-155-5p suppresses the migration and invasion of lung adenocarcinoma A549 cells by targeting Smad2
Jianfeng Lin et al.
ONCOLOGY LETTERS (2018)
PD-L1 expression is regulated by both DNA methylation and NF-kappa B during EMT signaling in non-small cell lung carcinoma
A. Asgarova et al.
ONCOIMMUNOLOGY (2018)
Characterization of selective exosomal microRNA expression profile derived from laryngeal squamous cell carcinoma detected by next generation sequencing
Qiang Huang et al.
ONCOLOGY REPORTS (2018)
Cancer Cell-intrinsic PD-1 and implications in Combinatorial immunotherapy
Han Yao et al.
FRONTIERS IN IMMUNOLOGY (2018)
Tobacco smoking and cessation and PD-L1 inhibitors in non-small cell lung cancer (NSCLC): a review of the literature
Jan Norum et al.
ESMO OPEN (2018)
PD-L1 (CD274) promoter methylation predicts survival in colorectal cancer patients
Diane Goltz et al.
ONCOIMMUNOLOGY (2017)
The Roles of microRNAs in Regulating the Expression of PD-1/PD-L1 Immune Checkpoint
Qingshui Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Cystatin A suppresses tumor cell growth through inhibiting epithelial to mesenchymal transition in human lung cancer
Yunxia Ma et al.
Oncotarget (2017)
Unique distribution of programmed death ligand 1 (PD-L1) expression in East Asian non-small cell lung cancer
Yunjian Pan et al.
JOURNAL OF THORACIC DISEASE (2017)
MiR-9-5p promotes cell growth and metastasis in non-small cell lung cancer through the repression of TGFBR2
Gang Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
PD-L1 expression in squamous-cell carcinoma and adenocarcinoma of the lung
Urska Janzic et al.
RADIOLOGY AND ONCOLOGY (2017)
Biomarkers of response to PD-1/PD-L1 inhibition
Saman Maleki Vareki et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Identification of the Cell-Intrinsic and -Extrinsic Pathways Downstream of EGFR and IFNγ That Induce PD-L1 Expression in Head and Neck Cancer
Fernando Concha-Benavente et al.
CANCER RESEARCH (2016)
Progression and metastasis of lung cancer
Helmut H. Popper
CANCER AND METASTASIS REVIEWS (2016)
Tumor-Intrinsic PD-L1 Signals Regulate Cell Growth, Pathogenesis, and Autophagy in Ovarian Cancer and Melanoma
Curtis A. Clark et al.
CANCER RESEARCH (2016)
miR-19a/b modulates lung cancer cells metastasis through suppression of MXD1 expression
Wenxia Hu et al.
ONCOLOGY LETTERS (2016)
MiR-21 and MiR-155 promote non-small cell lung cancer progression by downregulating SOCS1, SOCS6, and PTEN
Xinying Xue et al.
ONCOTARGET (2016)
PD-L1 expression as predictive biomarker in patients with NSCLC: a pooled analysis
Francesco Passiglia et al.
ONCOTARGET (2016)
PD-L1 expression in non-small cell lung cancer: Correlations with genetic alterations
Andreas H. Scheel et al.
ONCOIMMUNOLOGY (2016)
Tumor cell-intrinsic PD-L1 promotes tumor-initiating cell generation and functions in melanoma and ovarian cancer
Harshita B. Gupta et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2016)
MicroRNA-125b promotes tumor metastasis through targeting tumor protein 53-induced nuclear protein 1 in patients with non-small-cell lung cancer
Qinchuan Li et al.
CANCER CELL INTERNATIONAL (2015)
PD-1/PD-L1 inhibitors
Joel Sunshine et al.
CURRENT OPINION IN PHARMACOLOGY (2015)
MicroRNA-29b attenuates non-small cell lung cancer metastasis by targeting matrix metalloproteinase 2 and PTEN
Hongyan Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2015)
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients
A. D'Incecco et al.
BRITISH JOURNAL OF CANCER (2015)
HOPX is methylated and exerts tumour-suppressive function through Ras-induced senescence in human lung cancer
Yuan Chen et al.
JOURNAL OF PATHOLOGY (2015)
Wnt/β-Catenin and MAPK Signaling: Allies and Enemies in Different Battlefields
Daniele Guardavaccaro et al.
SCIENCE SIGNALING (2012)
DSC3 expression is regulated by p53, and methylation of DSC3 DNA is a prognostic marker in human colorectal cancer
T. Cui et al.
BRITISH JOURNAL OF CANCER (2011)
miRNA control of tumor cell invasion and metastasis
Somesh Baranwal et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer
Yuan Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Share Paper
